Learn ·

How to Reconstitute Lyophilized Peptides

Choosing a diluent, working out the concentration, and dissolving the powder without damaging it — the standard laboratory procedure, step by step.

Published Sep 20, 2026

Reconstitution means dissolving a freeze-dried (lyophilized) peptide back into solution. The short version: bring the vial to room temperature, add a sterile diluent — usually bacteriostatic water — slowly down the inside wall of the vial, and swirl gently until the powder dissolves. Never shake. The volume you add sets the concentration: milligrams in the vial ÷ millilitres added = mg/mL. Everything else in this guide is detail in service of those three sentences.

Why peptides arrive as a powder

Research peptides are shipped lyophilized because water is the medium for almost every degradation reaction a peptide can undergo — hydrolysis of the backbone, deamidation of asparagine and glutamine, and most oxidation chemistry all need it. Freeze-drying removes the water by sublimation and leaves a porous cake that is chemically quiet: in the solid state these reactions slow by orders of magnitude, which is why a sealed lyophilized vial tolerates days at room temperature in transit while the same peptide in solution would not. Reconstitution reverses that protection, so the clock on a peptide’s usable life effectively starts the moment the diluent goes in. (For what happens after that, see How to store peptides.)

What you need

  • The vial of lyophilized peptide, at room temperature.
  • A sterile diluent — see the next section. For the large majority of peptides this is bacteriostatic water (sterile water with 0.9% benzyl alcohol).
  • A sterile syringe and needle for transferring the diluent (a 1 mL or 3 mL syringe with a fine needle gives the most control).
  • Alcohol swabs for both rubber stoppers.
  • A label and a pen: name, concentration, date reconstituted.
  • A refrigerator (2–8 °C) for the finished solution.

Choosing the diluent

Bacteriostatic water is the default because it solves the multi-use problem. Its 0.9% benzyl alcohol is a preservative that suppresses microbial growth between draws, which is what makes it acceptable to enter the same vial repeatedly over several weeks; the compendial convention for preserved multi-dose vials is 28 days after first puncture. Plain sterile water for injection has no preservative and is intended for a single use — fine if you will consume the whole vial at once, otherwise not.

A minority of peptides need something else, and it is predictable from the sequence. The rule of thumb used by every peptide supplier: count the charged residues at neutral pH — lysine, arginine and histidine (plus the free N-terminus) are basic; aspartate and glutamate (plus the free C-terminus) are acidic. A peptide with a clear net positive or net negative charge dissolves readily in water. Peptides near neutral, or with long runs of hydrophobic residues, may not: basic peptides that resist water usually dissolve in dilute acetic acid, acidic ones in dilute ammonium bicarbonate, and very hydrophobic sequences may need a small volume of an organic co-solvent (DMSO or acetonitrile) before dilution with water. A few compounds are sensitive to benzyl alcohol itself — recombinant somatropin (HGH) is the familiar example, and its clinical labeling specifies the diluent. When a product needs a non-standard solvent, it is noted on that product’s page and profile.

Working out the volume

The diluent volume is a choice, not a fixed number, and it only determines how concentrated the solution is. Two things constrain it: the vial’s capacity (a standard 3 mL or 5 mL research vial takes up to about 2–3 mL comfortably), and the peptide’s solubility (very high concentrations of a poorly soluble peptide will not go into solution cleanly). Within those limits, pick the volume that makes your subsequent measurements convenient.

Peptide in vial + 1 mL diluent + 2 mL diluent + 3 mL diluent
5 mg 5 mg/mL (5,000 µg/mL) 2.5 mg/mL (2,500 µg/mL) 1.67 mg/mL (1,667 µg/mL)
10 mg 10 mg/mL (10,000 µg/mL) 5 mg/mL (5,000 µg/mL) 3.33 mg/mL (3,333 µg/mL)
20 mg 20 mg/mL (20,000 µg/mL) 10 mg/mL (10,000 µg/mL) 6.67 mg/mL (6,667 µg/mL)
30 mg 30 mg/mL (30,000 µg/mL) 15 mg/mL (15,000 µg/mL) 10 mg/mL (10,000 µg/mL)

To go from concentration to a measured amount, divide: amount needed ÷ concentration = volume. Example: a 10 mg vial reconstituted with 2 mL is 5 mg/mL, i.e. 5,000 µg/mL; an aliquot of 250 µg is therefore 250 ÷ 5,000 = 0.05 mL (50 µL), and the vial holds 40 such aliquots. The calculator below does this arithmetic for any combination.

Interactive

Reconstitution calculator

Concentration
5 mg/mL (5,000 µg/mL)
Volume per aliquot
0.05 mL (50 µL)
Aliquots per vial
40

Concentration = mg ÷ mL. Volume per aliquot = amount needed ÷ concentration. Laboratory arithmetic only — not dosing guidance; these compounds are for research use.

Step-by-step procedure

  1. Let the vial reach room temperature before opening it. A cold cake pulls condensation out of the air the moment the stopper is breached, and that moisture is exactly what lyophilization removed. Twenty minutes on the bench is enough.
  2. Swab both stoppers — the peptide vial and the diluent vial — with an alcohol swab and let them dry.
  3. Draw the chosen volume of diluent into the syringe.
  4. Insert the needle at an angle and let the diluent run down the inside wall of the vial. Do not aim the stream at the cake. A jet of liquid hitting the powder creates foam, and foam means an air–water interface, which is where peptides unfold, stick and aggregate.
  5. Swirl gently, or roll the vial between your palms. Most peptides dissolve within a minute or two; some take longer and are helped by simply letting the vial sit for ten minutes and swirling again. Do not shake and do not vortex.
  6. Inspect the solution against a light background. It should be clear and, for almost every peptide, colorless — copper peptides (GHK-Cu and blends that contain it) are a normal faint blue. Cloudiness or visible particles mean the peptide has not dissolved or has aggregated; see troubleshooting below.
  7. Label the vial with the peptide name, the concentration you have just created, and the date.
  8. Refrigerate at 2–8 °C, protected from light.

Common mistakes

  • Shaking to speed dissolution. Agitation is the single most common cause of peptide aggregation in the pharmaceutical stability literature; foaming is the visible sign.
  • Freezing the reconstituted solution, then thawing it repeatedly. Each freeze–thaw cycle concentrates the solutes at the ice front, shifts pH in buffered systems and creates fresh ice–water interfaces — all of which drive aggregation. If a solution must be frozen, aliquot it first and thaw each aliquot once.
  • Using non-sterile water (tap, distilled, bottled). Sterility and, for multi-use, a preservative are the whole point of the diluent.
  • Reusing needles or leaving the vial unstoppered. Every entry is a contamination opportunity; the preservative slows growth, it does not sterilize.
  • Making the solution extremely dilute. At low microgram-per-millilitre concentrations a measurable fraction of many peptides adsorbs to glass and plastic surfaces; keep working solutions reasonably concentrated and dilute at the point of use.
  • Losing track of the concentration. Unlabeled vials are the most common source of calculation errors weeks later.

Troubleshooting

The powder will not fully dissolve. Give it time — ten minutes and a second gentle swirl clears most cases. If particles persist, the peptide may be at the edge of its solubility at that concentration (add more diluent) or may need a pH adjustment based on its charge, as described above. Brief sonication in a bath sonicator is acceptable for stubborn research peptides; heating is not.

The solution foamed. Let it stand until the foam collapses. A small amount of foam once is not catastrophic, but it is a signal to change technique next time.

The solution turned cloudy after a few days in the refrigerator. That is aggregation or microbial growth; either way the vial should not be used for quantitative work. Cloudiness on day one, by contrast, is almost always incomplete dissolution.

The cake looked collapsed, shrunken or glassy on arrival. Cake appearance varies with the freeze-drying cycle and does not by itself indicate degradation. Purity is established by the lot’s certificate of analysis, not by how the cake looks — see How to read a peptide COA.

After reconstitution

A reconstituted peptide in bacteriostatic water is refrigerated and, by convention, used within 28 days — the preservative’s validated window rather than a property of the peptide. Some peptides are chemically robust for longer and some are not; the storage guide covers the chemistry of which is which, when freezing aliquots makes sense, and how to recognise a degraded solution.

Frequently asked questions

Straight answers to the questions researchers most often ask. Everything below summarizes published preclinical and clinical literature; it is not medical advice, and these compounds are supplied for laboratory research only.

What is the best water to reconstitute peptides with?

Bacteriostatic water — sterile water containing 0.9% benzyl alcohol as a preservative — is the standard for any vial that will be entered more than once. Sterile water for injection is appropriate only when the entire vial is used at once, because it has no preservative. A minority of peptides need a mildly acidic or basic diluent for solubility; those are noted on their product pages.

How much bacteriostatic water do you add to a 5 mg vial?

Any volume the vial can hold works — the amount only sets the concentration. 1 mL gives 5 mg/mL, 2 mL gives 2.5 mg/mL. Choose the volume that makes the amounts you will measure later convenient to draw accurately; 1–2 mL is typical for a 5 mg research vial.

Why should you never shake a peptide vial?

Shaking creates foam, and foam is an air–water interface where peptide molecules unfold, stick to one another and aggregate. Agitation is one of the best-documented causes of aggregation in the protein and peptide stability literature. Swirl or roll the vial gently instead and let it stand if needed.

Can you use sterile water instead of bacteriostatic water?

Yes, if the whole vial will be used in a single session. Sterile water has no preservative, so a vial reconstituted with it should not be stored and re-entered over days or weeks the way a bacteriostatic-water solution can be.

What does it mean if the reconstituted solution is cloudy?

Immediately after reconstitution, cloudiness usually means the peptide has not fully dissolved — wait ten minutes and swirl again, or add diluent. Cloudiness or particles that appear days later indicate aggregation or microbial growth, and that solution should not be used for quantitative research.

How long does a reconstituted peptide last?

Refrigerated at 2–8 °C in bacteriostatic water, the working convention is 28 days after reconstitution, which matches the preservative's validated multi-use window. Chemically robust peptides may remain within specification longer and fragile ones may not; the storage guide explains the degradation chemistry behind those differences.

Can you refreeze a reconstituted peptide?

Repeated freeze–thaw cycles are the fastest way to aggregate a peptide in solution. If a solution must be frozen, divide it into single-use aliquots first, freeze once, and thaw each aliquot only once.

Do peptides have to be reconstituted right away?

No. The lyophilized powder is the stable form; a sealed vial keeps for months refrigerated and longer frozen. Reconstitute only when the solution is actually needed.

References

  1. Wang W Lyophilization and development of solid protein pharmaceuticals International journal of pharmaceutics, 2000Why freeze-drying stabilizes peptides and proteins; residual moisture and cake properties.
  2. Wang W Instability, stabilization, and formulation of liquid protein pharmaceuticals International journal of pharmaceutics, 1999Degradation pathways that begin once a peptide is in solution.
  3. Meyer BK, Ni A, Hu B et al. Antimicrobial preservative use in parenteral products: past and present Journal of pharmaceutical sciences, 2007Benzyl alcohol and the rationale for preserved multi-dose vials.
  4. Manning MC, Chou DK, Murphy BM et al. Stability of protein pharmaceuticals: an update Pharmaceutical research, 2010Agitation, interfaces and aggregation — the case against shaking.
  5. Zapadka KL, Becher FJ, Gomes Dos Santos AL et al. Factors affecting the physical stability (aggregation) of peptide therapeutics Interface focus, 2017Concentration, interfaces, pH and sequence as drivers of peptide aggregation.
  6. Lai MC, Topp EM Solid-state chemical stability of proteins and peptides Journal of pharmaceutical sciences, 1999Moisture as the dominant variable in solid-state (lyophilized) stability.
  7. Zäh M, Brandenbusch C, Artusio F et al. DSC reveals the excipient impact on aggregation propensity of pharmaceutical peptides during freezing European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2025Freezing-induced aggregation of peptides in solution.
  8. Feickert M, Burckhardt BB A design of experiments concept for the minimization of nonspecific peptide adsorption in the mass spectrometric determination of substance P and related hemokinin-1 Journal of separation science, 2020Nonspecific adsorption of dilute peptides to labware.